du-21220 has been researched along with prenalterol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Broadley, KJ; Grassby, PF | 1 |
| Balsiger, BM; Haefliger, S; Rickenbacher, A; Seiler, R; Shaw, S | 1 |
3 other study(ies) available for du-21220 and prenalterol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Responses mediated via beta-1 adrenoceptors but not beta-2 adrenoceptors exhibit supersensitivity after chronic reserpine pretreatment.
Topics: Animals; Blood Vessels; Carbachol; Dose-Response Relationship, Drug; Female; Guinea Pigs; Heart Rate; Ileum; In Vitro Techniques; Isoproterenol; Lung; Male; Myocardial Contraction; Norepinephrine; Practolol; Prenalterol; Receptors, Adrenergic, beta; Reserpine; Ritodrine; Trachea; Vas Deferens; Vasoconstriction | 1986 |
Role of selective alpha and beta adrenergic receptor mechanisms in rat jejunal longitudinal muscle contractility.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Animals; Clonidine; Disease Models, Animal; Dose-Response Relationship, Drug; Gastrointestinal Motility; Jejunum; Male; Muscle Contraction; Muscle, Smooth; Norepinephrine; Phenylephrine; Prenalterol; Rats; Rats, Wistar; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Ritodrine | 2008 |